Even in the US, infectious diseases are the third most common cause of death, despite the widespread availability of antibiotics, vaccines, and advanced hygienic standards. The identification of new pathogens, the re-emergence of old pathogens, and the increasing incidence of antibiotic resistance reflect the globalization of humanity and microbes. As illustrated by the recent anthrax, SARS, and monkeypox outbreaks, new as well as old pathogens can be rapidly moved great distances and establish footholds in new niches. Strategies for the prevention, treatment, and control of infectious diseases will require fundamental bench research that takes advantages of rapid advances in genomics, proteomics, cell biology, and immunology to develop new diagnostics, therapeutics, and vaccines. The study of microbial pathogenesis is a rapidly advancing area of research, with unprecedented opportunity to influence health worldwide. Over the past 5 years, UCSF has created a strong training environment and established an outstanding program in Infectious Disease and Host Defense. There are 26 faculty already associated with the program and several new hires planned; space and resources to recruit 2-3 more faculty have been allocated; a course, journal club and research talks are now offered, and a yearly symposium established. This new T32 grant application describes the new program at UCSF in Microbial Pathogenesis and Host Defense that will train the next generation of scientists who can combat disease through advances in basic and translational research. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
1T32AI060537-01
Application #
6801603
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
2004-08-01
Project End
2009-07-31
Budget Start
2004-08-01
Budget End
2005-07-31
Support Year
1
Fiscal Year
2004
Total Cost
$180,528
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Binning, Jennifer M; Smith, Amber M; Hultquist, Judd F et al. (2018) Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. PLoS Pathog 14:e1006830
Shenoy, Meera K; Lynch, Susan V (2018) Role of the lung microbiome in HIV pathogenesis. Curr Opin HIV AIDS 13:45-52
Dolan, Patrick T; Whitfield, Zachary J; Andino, Raul (2018) Mapping the Evolutionary Potential of RNA Viruses. Cell Host Microbe 23:435-446
Dornfeld, Dominik; Dudek, Alexandra H; Vausselin, Thibaut et al. (2018) SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Sci Rep 8:2092
Borges, Adair L; Davidson, Alan R; Bondy-Denomy, Joseph (2017) The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs. Annu Rev Virol 4:37-59
Keck, Kristin M; Moquin, Stephanie A; He, Amanda et al. (2017) Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps. J Biol Chem 292:13284-13295
Rauch, Benjamin J; Silvis, Melanie R; Hultquist, Judd F et al. (2017) Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell 168:150-158.e10
Bouquet, Jerome; Melgar, Michael; Swei, Andrea et al. (2017) Metagenomic-based Surveillance of Pacific Coast tick Dermacentor occidentalis Identifies Two Novel Bunyaviruses and an Emerging Human Ricksettsial Pathogen. Sci Rep 7:12234
Fontana, Mary F; de Melo, Gabrielly L; Anidi, Chioma et al. (2017) Correction: Macrophage Colony Stimulating Factor Derived from CD4+ T Cells Contributes to Control of a Blood-Borne Infection. PLoS Pathog 13:e1006192
Ruch, Travis R; Bryant, David M; Mostov, Keith E et al. (2017) Par3 integrates Tiam1 and phosphatidylinositol 3-kinase signaling to change apical membrane identity. Mol Biol Cell 28:252-260

Showing the most recent 10 out of 107 publications